Trial intelligence / Profile preview

Insulin Lispro Low Mix vs Human Insulin Mix 30/70 in Diabetes

NCT00420095Phase 4Completed

Sponsor
Eli Lilly and Company
Start
Jan 2007
Primary completion
Jan 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin lispro in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Jan 2007; status: completed.

02

Drugs

insulin lispro
03

Conditions

type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00420095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00420095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call